Latest Articles
- Medical management of benign prostatic hyperplasia
The goal is to maximize quality of life and minimize “bothersome” symptoms. Choices about medical therapy are guided by indication, effectiveness, side effects, as well as patient preference.
- Is there a role for chronic suppressive therapy in herpes simplex virus infection?
Yes, in patients with recurrent oral and genital HSV-2 infection and oral HSV-1 infection.
- Hypertension and severe hyperreninemia in a young man
A 29-year-old man with blood pressure measurements of 152/118 mm Hg and 156/116 mm Hg at 2 separate clinic visits is started on combination antihypertensive therapy and undergoes evaluation for secondary causes of hypertension.
- When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?
In the January 2024 issue, the article “When should we consider SGLT-2 inhibitors in patients with acute decompensated heart failure?” by Badwan OZ et al [Cleve Clin J Med 2024; 91(1):47–51. doi:10.3949/ccjm.91a.23034] contained an error in Figure 1.
- Does my patient have testosterone deficiency?
Diagnosis of testosterone deficiency requires the presence of relevant signs or symptoms along with biochemical evidence.
- Dealing with the “T” (testosterone)
If a patient feels better when taking testosterone supplementation, is it the “T” or is it a placebo effect?
- What are the management considerations for venous thromboembolic events in patients with cirrhosis?
The authors review the current evidence on venous thromboembolic event (VTE) risk prediction in patients with cirrhosis, as well as VTE prophylaxis and anticoagulant therapy.